Bundamedik Tbk PT (BMHS) — Cash Flow Quality Index
Bundamedik Tbk PT (BMHS) has a Cash Flow Quality Index of 1172.10x as of December 2025. Operating cash flow of Rp199.64 Billion exceeds net income of Rp170.33 Million, indicating high earnings quality where cash backs reported profits. Also explore BMHS current and non-current assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Bundamedik Tbk PT Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Bundamedik Tbk PT across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Bundamedik Tbk PT's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Bundamedik Tbk PT (2018–2025)
Year-by-year earnings quality comparison for Bundamedik Tbk PT. For live market cap and the full company financial profile, see market cap of Bundamedik Tbk PT.
| Year | Quality Index | Operating CF (IDR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 20.18x | Rp250.62 Billion | Rp12.42 Billion | ▲ +609.3% |
| 2024 | 2.85x | Rp33.98 Billion | Rp11.94 Billion | ▼ -58.7% |
| 2023 | 6.89x | Rp51.44 Billion | Rp7.46 Billion | ▲ +274.3% |
| 2022 | 1.84x | Rp237.47 Billion | Rp128.93 Billion | ▲ +13.1% |
| 2021 | 1.63x | Rp349.44 Billion | Rp214.49 Billion | ▼ -24.0% |
| 2020 | 2.14x | Rp190.36 Billion | Rp88.79 Billion | ▼ -52.5% |
| 2019 | 4.51x | Rp89.72 Billion | Rp19.89 Billion | ▼ -47.2% |
| 2018 | 8.54x | Rp43.79 Billion | Rp5.13 Billion | — |